10-K/A: AdaptHealth Files Amended Annual Report to Include Omitted Equity Compensation Details

AdaptHealth Corp. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, solely to include the previously omitted Equity Compensation Plan Table.

Summary

• AdaptHealth Corp. (AHCO) filed an Amendment No. 1 on Form 10-K/A to its Annual Report for the fiscal year ended December 31, 2024.
• The amendment's sole purpose is to include the Equity Compensation Plan Table in Part III, Item 12, which was inadvertently omitted from the original 10-K filing.
• As of December 31, 2024, a total of 5,898,675 securities are to be issued upon the exercise of outstanding options, warrants, and rights, with a weighted-average exercise price of $9.67.
• There are 9,760,715 securities remaining available for future issuance under equity compensation plans.
• Specifically, the A&R 2019 Stock Incentive Plan accounts for 5,115,684 issuable securities (weighted-average exercise price of $9.67) and 9,138,317 securities available for future issuance.
• The 2019 Employee Stock Purchase Plan has 622,398 securities remaining available for future issuance.
• An additional 782,991 service-based and performance-based restricted stock units were granted to Suzanne Foster outside the A&R 2019 Plan as an inducement for her employment.
• The aggregate market value of common stock held by non-affiliates was approximately $1.07 billion as of June 28, 2024, based on a closing sale price of $10.00 per share.
• As of February 21, 2025, there were 134,867,011 shares of the Registrant's Common Stock outstanding.
• The report includes certifications from CEO Suzanne Foster and CFO Jason Clemens, affirming the accuracy of the amendment.

Sentiment

Score: 5

Explanation: The document is neutral in sentiment as it is a corrective administrative filing, not providing new positive or negative operational or financial performance updates.

Positives

• The company is proactively correcting an administrative oversight, demonstrating commitment to regulatory compliance and transparency.
• The inclusion of the Equity Compensation Plan Table provides complete disclosure regarding outstanding equity awards and available shares, enhancing investor clarity.

Negatives

• The initial omission of the Equity Compensation Plan Table from the original 10-K filing indicates an administrative error in the reporting process.

Risks

• The document does not introduce new risks; it is a corrective filing. However, the existence of equity compensation plans inherently carries the risk of dilution for existing shareholders as new shares are issued upon exercise or vesting.

Future Outlook

This amendment does not contain any new forward-looking statements or guidance; it solely corrects an omission from a previously filed annual report.

Management Comments

• Suzanne Foster, Chief Executive Officer and Director, certified that, based on her knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made not misleading.
• Jason Clemens, Chief Financial Officer, certified that, based on his knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made not misleading.

Industry Context

This filing is an administrative amendment to an annual report and does not provide information related to broader industry trends or competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides complete transparency regarding the company's equity compensation plans, including potential dilution from outstanding options and available shares for future issuance.
• Regulatory Authorities: Demonstrates the company's commitment to correcting reporting errors and maintaining compliance with SEC disclosure requirements.

Next Steps

• The company will continue to file reports with the SEC as required by Section 13 or 15(d) of the Securities Exchange Act of 1934.

Key Dates

Keywords

AdaptHealth, AHCO, SEC Filing, 10-K/A, Annual Report Amendment, Equity Compensation, Stock Incentive Plan, Employee Stock Purchase Plan, Stock Options, Restricted Stock Units, Corporate Governance, Financial Reporting